Skip to main content
Log in

Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia

  • Review Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

Androgenetic alopecia (AGA), also termed as androgenic alopecia or common baldness, is a condition where there is androgen mediated conversion of susceptible terminal hair into vellus hair. Although it is reported more commonly in males, it also affects females but the incidence is relatively unknown. AGA tremendously affects the psychology of the patient due to its chronicity of treatment and cosmetic implications. There are numerous treatment options available for AGA but the choice of treatment has to often be tailored according to the patient’s needs, affordability, and compliance. This review focusses on the various treatment options available, with special emphasis on the role of low-level laser therapy (LLLT) in the management of AGA. The literature research considered published journal articles (clinical trials or scientific reviews). Studies were identified by searching electronic databases (MEDLINE and PubMed) and reference lists of respective articles. Only articles available in English were considered for this review.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53(3):708–728

    CAS  PubMed  Google Scholar 

  2. Otberg N, Finner AM, Shapiro J (2007) Androgenetic Alopecia. Endocrinol Metab Clin N Am 36(2):379–398

    CAS  Google Scholar 

  3. Paus R, Cotsarelis G. The biology of hair follicles. Epstein FH, editor. N Engl J Med 1999;341(7):491–497

  4. Rousso DE, Kim SW (2014) A review of medical and surgical treatment options for androgenetic alopecia. JAMA Facial Plast Surg 16(6):444

    PubMed  Google Scholar 

  5. Avci P, Gupta GK, Clark J, Wikonkal N, Hamblin MR (2014) Low-level laser (light) therapy (LLLT) for treatment of hair loss: LLLT for hair regrowth. Lasers Surg Med 46(2):144–151

    PubMed  Google Scholar 

  6. Faghihi G, Mozafarpoor S, Asilian A, Mokhtari F, Esfahani A, Bafandeh B et al (2018) The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia. Indian J Dermatol Venereol Leprol 84(5):547

    PubMed  Google Scholar 

  7. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W et al (1998) Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 39(4):578–589

    CAS  PubMed  Google Scholar 

  8. Van Neste D, Fuh V, Sanchez-Pedreno P, Lopez-Bran E, Wolff H, Whiting D et al (2000) Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol 143(4):804–810

    PubMed  Google Scholar 

  9. Caserini M, Radicioni M, Leuratti C, Terragni E, Iorizzo M, Palmieri R (2016) Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. Int J Clin Pharmacol Ther 54(01):19–27

    CAS  PubMed  Google Scholar 

  10. Irwig MS (2012) Persistent sexual side effects of finasteride: could they be permanent? J Sex Med 9(11):2927–2932

    PubMed  Google Scholar 

  11. Finasteride for androgenetic alopecia and side effects [Internet]. [cited 2019 Sep 16]. Available from: https://www.clinicaldermatology.eu/materiale_cic/719_1_4/6207_finasteride/article.htm

  12. Hajheydari Z, Akbari J, Saeedi M, Shokoohi L (2009) Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia. Indian J Dermatol Venereol Leprol 75(1):5

    Google Scholar 

  13. Drobnis EZ, Nangia AK (2017) 5α-reductase inhibitors (5ARIs) and male reproduction. Adv Exp Med Biol 1034:59–61

    PubMed  Google Scholar 

  14. Tsunemi Y, Irisawa R, Yoshiie H, Brotherton B, Ito H, Tsuboi R et al (2016) Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. J Dermatol 43(9):1051–1058

    CAS  PubMed  Google Scholar 

  15. Prager N, Bickett K, French N, Marcovici G (2002) A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med 8(2):143–152

  16. Rossi A, Mari E, Scarnò M, Garelli V, Maxia C, Scali E et al (2012) Comparitive effectiveness and finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. Int J Immunopathol Pharmacol 25(4):1167–1173

    CAS  PubMed  Google Scholar 

  17. Sovak M, Seligson AL, Kucerova R, Bienova M, Hajduch M, Bucek M (2002) Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience. Dermatol Surg 28(8):678–685

    PubMed  Google Scholar 

  18. Rathnayake D, Sinclair R (2010) Male androgenetic alopecia. Expert Opin Pharmacother 11(8):1295–1304

    CAS  PubMed  Google Scholar 

  19. Goren A, Sharma A, Dhurat R, Shapiro J, Sinclair R, Situm M et al (2018) Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients. Dermatol Ther 31(6):e12741

    CAS  PubMed  Google Scholar 

  20. Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S (2012) Minoxidil use in dermatology, side effects and recent patents. Recent Patents Inflamm Allergy Drug Discov 6(2):130–136

    CAS  Google Scholar 

  21. Bienová M, Kuerová R, Fiurá M (2005) Androgenetic alopecia and current methods of treatment. Androg Alopecia 14(1):4

    Google Scholar 

  22. Senel E, Purnak T, Sahin C (2011) Liquid formulation of minoxidil versus its foam formulation. Indian J Dermatol 56(4):462

    PubMed  PubMed Central  Google Scholar 

  23. Blumeyer A, Tosti A, Messenger A, Reygagne P, del Marmol V, Spuls PI et al (2011) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. JDDG J Dtsch Dermatol Ges 9:S1–S57

    PubMed  Google Scholar 

  24. Gupta AK, Charrette A (2015) Topical minoxidil: systematic review and meta-analysis of its efficacy in androgenetic alopecia. Skinmed. 13(3):185–189

    PubMed  Google Scholar 

  25. Chitalia J, Dhurat R, Goren A, McCoy J, Kovacevic M, Situm M et al (2018) Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian subcontinent. Dermatol Ther 31(6):e12688

    PubMed  Google Scholar 

  26. Goren A, Shapiro J, Roberts J, McCoy J, Desai N, Zarrab Z et al (2015) Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatol Ther 28(1):13–16

    PubMed  Google Scholar 

  27. Li ZJ, Choi H-I, Choi D-K, Sohn K-C, Im M, Seo Y-J et al (2012) Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 38(7pt1):1040–1046

    CAS  PubMed  Google Scholar 

  28. Lotti T, Goren A, Verner I, D’Alessio PA, Franca K (2019) Platelet rich plasma in androgenetic alopecia: a systematic review. Dermatol Ther 32(3):e12837

    PubMed  Google Scholar 

  29. Cervelli V, Garcovich S, Bielli A, Cervelli G, Curcio BC, Scioli MG et al (2014) The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int 2014:1–9

    Google Scholar 

  30. Puig CJ, Reese R, Peters M (2016) Double-blind, Placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia. Dermatol Surg 42(11):1243–1247

    CAS  PubMed  Google Scholar 

  31. Ayatollahi A, Hosseini H, Shahdi M, AhmadNasrollahi S, NassiriKashani M, Yadangi S et al (2017) Platelet-rich plasma by single spin process in male pattern androgenetic alopecia: is it an effective treatment? Indian Dermatol Online J 8(6):460–464

    PubMed  PubMed Central  Google Scholar 

  32. Stevens J, Khetarpal S (2019) Platelet-rich plasma for androgenetic alopecia: a review of the literature and proposed treatment protocol. Int J Womens Dermatol 5(1):46–51

    CAS  PubMed  Google Scholar 

  33. Schmidt B, Horsley V (2012) Unravelling hair follicle-adipocyte communication. Exp Dermatol 21(11):827–830

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Rossi A, Anzalone A, Fortuna MC, Caro G, Garelli V, Pranteda G et al (2016) Multi-therapies in androgenetic alopecia: review and clinical experiences: an update and future potential treatments. Dermatol Ther 29(6):424–432

    PubMed  Google Scholar 

  35. Patwardhan N, Mysore V (2008) Hair transplantation: standard guidelines of care. Indian J Dermatol Venereol Leprol 74(Suppl):S46–53

  36. Kassimir JJ (1987) Use of topical minoxidil as a possible adjunct to hair transplant surgery. J Am Acad Dermatol 16(3):685–687

    CAS  PubMed  Google Scholar 

  37. Leavitt M, David P-M, Rao NA, Barusco M, Kaufman KD, Ziering C (2006) Effects of finasteride (1 mg) on hair transplant. Dermatol Surg 31(10):1268–1276

    Google Scholar 

  38. Dhurat R, Mathapati S (2015) Response to microneedling treatment in men with androgenetic alopecia who failed to respond to conventional therapy. Indian J Dermatol 60(3):260

    PubMed  PubMed Central  Google Scholar 

  39. Verner I, Lotti T (2018) Clinical evaluation of a novel fractional radiofrequency device for hair growth: fractional radiofrequency for hair growth stimulation. Dermatol Ther 31(3):e12590

    PubMed  Google Scholar 

  40. Maddin WS, Bell PW, James JH (1990) The biological effects of a pulsed electrostatic field with specific reference to hair. Electrotrichogenesis Int J Dermatol 29(6):446–450

    CAS  PubMed  Google Scholar 

  41. Doghaim NN, El-Tatawy RA, Neinaa YME, Abd El-Samd MM (2018) Study of the efficacy of carboxytherapy in alopecia. J Cosmet Dermatol 17(6):1275–1285

    PubMed  Google Scholar 

  42. Ghanaat M (2010) Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism. South Med J 103(9):917–921

    PubMed  Google Scholar 

  43. Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR et al (2014) Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, Double-blind Study. Am J Clin Dermatol 15(2):115–127

    PubMed  PubMed Central  Google Scholar 

  44. Kruglikov IL, Zhang Z, Scherer PE (2019) The role of immature and mature adipocytes in hair cycling. Trends Endocrinol Metab 30(2):93–105

    CAS  PubMed  Google Scholar 

  45. Leavitt M, Charles G, Heyman E, Michaels D (2009) HairMax LaserComb® laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled. Multicentre Trial Clin Drug Investig 29(5):283–292

    PubMed  Google Scholar 

  46. Kim H, Choi JW, Kim JY, Shin JW, Lee S, Huh C-H (2013) Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, Sham Device–Controlled Multicenter Trial. Dermatol Surg 39(8):1177–1183

    CAS  PubMed  Google Scholar 

  47. Suchonwanit P, Chalermroj N, Khunkhet S (2019) Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial. Lasers Med Sci 34(6):1107–1114

    PubMed  Google Scholar 

  48. Mai-Yi Fan S, Cheng Y-P, Lee M-Y, Lin S-J, Chiu H-Y (2018) Efficacy and safety of a low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, self-comparison, sham device-controlled trial. Dermatol Surg Off Publ Am Soc Dermatol Surg Al 44(11):1411–1420

    CAS  Google Scholar 

  49. Lanzafame RJ, Blanche RR, Bodian AB, Chiacchierini RP, Fernandez-Obregon A, Kazmirek ER (2013) The growth of human scalp hair mediated by visible red light laser and LED sources in males: the growth of human scalp hair. Lasers Surg Med 45(8):487–495

    PubMed  Google Scholar 

  50. Lanzafame RJ, Blanche RR, Chiacchierini RP, Kazmirek ER, Sklar JA (2014) The growth of human scalp hair in females using visible red light laser and LED sources: growth of scalp hair in women. Lasers Surg Med 46(8):601–607

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamad Goldust.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Disclaimer

“We confirm that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met and that each author believes that the manuscript represents honest work.”

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Galadari, H., Shivakumar, S., Lotti, T. et al. Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia. Lasers Med Sci 35, 1239–1244 (2020). https://doi.org/10.1007/s10103-020-02994-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-020-02994-4

Keywords

Navigation